Dihydroetorphine Hydrochloride

盐酸二氢埃托啡

Report date: 2025/09/23 16:13:35
NME

Base Information

Drug NameDihydroetorphine Hydrochloride
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionOpioid receptors agonists
TargetsOpioid receptors
Therapy Area/IndicationsCancer PainPain, Postoperative
Global Approved IndicationsCancer PainPain, Postoperative
Approved Indications in ChinaCancer PainPain, Postoperative
Original Approved Country/TerritoryMainland China
Original Approved Date2000/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Wellso Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBeijing Wellso Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCancer PainPain, Postoperative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A